Ontology highlight
ABSTRACT: Objectives
Peru has had the highest death toll from the pandemic worldwide; however, it is not clear what the effects of the different variants on these outcomes are. The study aimed to evaluate the risk of death, hospitalization, and intensive care unit (ICU) admission rates of COVID-19 according to the SARS-CoV-2 variants detected in Peru from March 2020-February 2022.Methods
Retrospective study using open-access databases were published by the Peruvian Ministry of Health. Databases of genomic sequencing, death, COVID-19 cases, hospitalization and ICU, and vaccination were used. Crude and adjusted Cox proportional hazards regressions with clustered variances were modeled to calculate the hazard ratio (HR) of outcomes by variant.Results
Lambda variant had the highest risk of death (HR 1.92, 95% CI 1.37-2.68), whereas the Delta variant had the lowest risk (HR 0.50, 95% CI 0.31-0.82). Mu variant had the highest risk of hospitalization (HR: 2.39, 95% CI 1.56-3.67), Omicron the lowest (HR 0.45, 95%CI 0.23-0.90), and Gamma had the highest ICU admission rate (HR 1.95, 95%CI 1.40-2.71).Conclusion
SARS-CoV-2 variants showed distinctive risks of clinical outcomes, which could have implications for the management of infected persons during the pandemic.
SUBMITTER: Fano-Sizgorich D
PROVIDER: S-EPMC9763211 | biostudies-literature | 2022 Dec
REPOSITORIES: biostudies-literature
Fano-Sizgorich Diego D Vásquez-Velásquez Cinthya C Orellana Laura R LR Ponce-Torres Christian C Gamboa-Serpa Henry H Alvarez-Huambachano Keyla K Gonzales Gustavo F GF
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20221220
<h4>Objectives</h4>Peru has had the highest death toll from the pandemic worldwide; however, it is not clear what the effects of the different variants on these outcomes are. The study aimed to evaluate the risk of death, hospitalization, and intensive care unit (ICU) admission rates of COVID-19 according to the SARS-CoV-2 variants detected in Peru from March 2020-February 2022.<h4>Methods</h4>Retrospective study using open-access databases were published by the Peruvian Ministry of Health. Data ...[more]